Drugs & Targets FDA launches crowdsourcing challenge to solicit input on research questions to be addressed through agency’s oncologic clinical trial data May 21, 2021Vol.47 No.20
Real-world Evidence Cancer trials are getting harder to complete, suggesting a role for more powerful RWE, AI solutions May 14, 2021Vol.47 No.19By Matthew Bin Han Ong
Trials & Tribulations It’s time to rethink clinical trials in a post-pandemic world May 14, 2021Vol.47 No.19By Dana Dornsife
In Brief Dana-Farber receives $50M gift from the Hale family for pancreatic cancer research May 14, 2021Vol.47 No.19
In Brief Christopher Lathan named chief clinical access and equity officer at Dana-Farber May 14, 2021Vol.47 No.19
In Brief MD Anderson, Broad Institute establish translational research platform focused on rare cancers May 14, 2021Vol.47 No.19
In Brief Jeffrey Miller receives $9M NCI grant to develop off-the-shelf NK cells May 14, 2021Vol.47 No.19
In Brief Leukemia & Lymphoma Society establishes IMPACT research grants to help underserved patients access clinical trials May 14, 2021Vol.47 No.19
